Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel L. Kisner currently holds 2,200 shares of Oncternal Therapeutics, Inc. (ONCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel L. Kisner has been a net seller of ONCT stock. They have purchased $57.6K and sold $272.8K worth of shares.
Daniel L. Kisner's most recent insider trade was on Jun 20, 2024, when they sold 2,200 shares at $0.00 per share.
Daniel L. Kisner serves as Executive at Oncternal Therapeutics, Inc. (ONCT). They have executed 111 insider transactions totaling $330.4K over their tenure at the company.
Daniel L. Kisner holds the position of Executive at Oncternal Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Daniel L. Kisner has shown a selling trading pattern, with $57.6K in total purchases and $272.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel L. Kisner was on May 19, 2008, when they sold $37.1K worth of CALP shares. This transaction involved 10,610 shares at $3.50 per share.
Daniel L. Kisner currently owns 2,200 shares of Oncternal Therapeutics, Inc. (ONCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel L. Kisner's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel L. Kisner has 111 Form 4 filings on record as an insider at Oncternal Therapeutics, Inc..
Set alerts for Daniel L. Kisner and 40,000+ other insiders.